Xeris Biopharma Holdings, Inc. earnings per share and revenue

XERS earnings per share for the last quarter are -0.03 USD whereas the estimation was -0.06 USD which accounts for 46.22% surprise. Company revenue for the same period amounts to 57.00 M USD despite the estimated figure of 58.10 M USD. Estimated earnings per share for the next quarter are -0.05 USD, and revenue is expected to reach 57.62 M USD. Also watch annual changes over time to get a bigger picture of XERS earnings per share and revenue dynamics.